Most new genes arise through the duplication of existing genes. In most cases, the duplication is not limited to the coding sequence but encompasses the regulatory region as well. The NBPF gene family has expanded during recent primate evolution, and it has no known mouse ortholog. One of its members, NBPF1, was found to be disrupted by a constitutional translocation in a neuroblastoma patient. Here, we show that the ancestral NBPF gene copied the regulatory region from an unrelated gene, EVI5, after the split between simians and prosimians but before simian radiation. Phylogenetic analysis points to the possible involvement of positive selection acting on the NBPF1 promoter in the simian lineage. We previously showed decreased NBPF1 expression in certain neuroblastoma cell lines. Here, we show that this expression pattern is mimicked by the EVI5 gene, but partly by different mechanisms. Epigenetic regulation of the EVI5 promoter is common in neuroblastoma cell lines, but it is not for the NBPF promoters. Here, we describe the recent acquisition of the NBPF1 promoter from an unrelated gene, and remarkably, both the donor (EVI5) and acceptor (NBPF1) genes are disrupted by constitutional translocations in patients with neuroblastoma, suggesting a functional link between these genes and the disease.
Introduction
New genes are generated mainly by the duplication of existing genes and subsequent mutation of the two resulting paralogs (Ohno 1970) . This is demonstrated by the existence of gene families such as the cadherins (Hulpiau and van Roy 2009 ) and the globins (Shen et al. 1981) . The evolutionary history of these genes can be tracked throughout the genomes of distantly related species. However, certain human gene families do not seem to have clear orthologs in the mouse genome and some appear to be primate-specific (Johnson et al. 2001; Vandepoele et al. 2005; Hodzic et al. 2006; Bosch et al. 2007 ). The recent origin of these genes and the positive selection acting on some of them (Johnson et al. 2001 ) means that they might have been key players in the evolution of man.
When new genes arise, their fate depends on several parameters, such as the possibility of ensuring expression of the transcript. In some cases, the regulatory region of the ancestral gene is also transferred to the daughter gene (reviewed in Carroll 2005) . Alternatively, new genes can acquire a promoter from an alien gene; this has been demonstrated for instance in Drosophila (Nurminsky et al. 1998; Betran and Long 2003; Usakin et al. 2005) and Xiphophorus (Fornzler et al. 1996) .
We recently identified the NBPF gene family (Neuroblastoma BreakPoint Family) that shows a remarkable copy number gain in the human genome as compared with other primates (Vandepoele et al. 2005; Popesco et al. 2006) . NBPF1, the founding member of this family, was identified through the cloning of the breakpoints of a constitutional translocation in a neuroblastoma patient (Vandepoele et al. 2008) . Neuroblastoma, a tumor derived from pluripotent neuroblasts, is the most frequent extracranial solid malignancy of childhood (Brodeur 2003) . We showed that the expression level of NBPF1 is severely decreased in neuroblastoma cell lines with loss of heterozygosity for the NBPF1 locus (Vandepoele et al. 2008) . Although this might be explained by the lower gene copy number, it is striking that such downregulation was observed for only 15-20% of the genes located in this region (Janoueix-Lerosey et al. 2004) , showing that additional mechanisms besides loss of heterozygosity play a role in the downregulation of some of these genes.
In this study, we identified the regulatory region of NBPF1, and we show that it was obtained from the unrelated EVI5 gene after the split between simians and prosimians. NBPF1 and EVI5 genes showed similar expression patterns in neuroblastoma cell lines, but this was found to be due to different mechanisms. Although we observed frequent epigenetic silencing of EVI5, we obtained evidence for potential mutational silencing of the NBPF1 gene in a number of neuroblastoma cell lines.
Materials and Methods

Plasmid Construction
To amplify promoter regions, we performed polymerase chain reaction (PCR) on normal genomic DNA using Pfu DNA polymerase (Promega, Madison, WI) and primers 5#-GCCGGTACCGTTAATAAATTTAAATTAG-3# (KpnI site underlined) and 5#-TAAAGCTTGGGTGCGGGGT-CAGTGTC-3# (HindIII site underlined) for NBPF1, and primers 5#-CGGTACCAAGACACGTGTAAGAGTACA-3# (KpnI site underlined) and 5#-TAAAGCTTGGGTG-CAGGGTCAGTGTC-3# (HindIII site underlined) for EVI5 NBPF . After digesting the amplified fragments with KpnI and HindIII, they were ligated in the pGL4.10(luc2) vector (Promega) that had been digested with the same enzymes.
The promoter fragments B-H were obtained in a similar way for NBPF1 and EVI5 NBPF . Fragments B-F were obtained by digesting the plasmids comprising the A fragments with HindIII and StuI (to obtain B), KpnI and NruI (for C), StuI and NruI (for D), KpnI and StuI (for E), or HindIII and NruI (for F). After blunting the sites, plasmids were self-ligated. To obtain fragments G, we digested the plasmids containing fragments F with KpnI and StuI, blunted the KpnI sites, and self-ligated the plasmids. To obtain fragments H, we digested the plasmids containing fragments G with BglI and allowed the plasmids to recircularize. The vector with NBPF1 fragment I was constructed by digesting the vector containing the NBPF1 fragment G with BamHI, blunting this site, and digesting the DNA with XbaI. This fragment was ligated into the pGL4.10(luc2) vector predigested with EcoRV and XbaI. The J fragments were constructed by digesting the constructs containing the H fragments with EagI (for construct J1), PvuII (for J2), BamHI (for J3), or StyI (for J4). After blunting, the DNAs were digested with SpeI. Fragments were then isolated and cloned into the pGL4.10(luc2) predigested with EcoRV and SpeI.
The EVI5 ALT promoter was amplified by using primers 5#-CGGTACCGCTGTAGGAGCTGAAAATGTTAG-3# (KpnI site underlined) and 5#-CCAAGCTTGAGAAA-TGTGAAGCCCATACAG-3# (HindIII site underlined). This fragment was cloned in pGEM-T Easy (Promega). After linearization with HindIII, a partial digestion was performed with KpnI, and the resulting promoter fragment was transferred to the pGL4.10(luc2) vector predigested with KpnI and HindIII.
Cell Culture, Transfections, and Luciferase Assays 293T and HeLa cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) containing 10% fetal calf serum. Transfections were performed by the calcium phosphate precipitation method (293T) or with Fugene (HeLa; Roche Applied Science, Vilvoorde, Belgium). The neuroblastoma cell lines SK-N-SH, SH-SY-5Y, GI-M-EN, STA-NB-1.2, CHP901, SMS-KAN, and LA-N-5 were kindly provided by Prof F. Speleman (Center for Medical Genetics, Ghent University Hospital, Belgium). Transfection of the neuroblastoma cell lines was done with FuGENE HD (Roche) in a 5:2 Fugene HD:DNA ratio. Luciferase activity was measured with a Galacto-Star kit (Tropix, Applied Biosystems, Lennik, Belgium) 48 h after transfection. Transfection was normalized by measuring b-galactosidase (Galacto-Star; Tropix, Applied Biosystems), encoded by the cotransfected pUT651 plasmid (Eurogentec, Seraing, Belgium). All transfections were done in duplicate and at least twice.
Cell Treatments
Cells were treated for 5 days with 1 lM 5-aza-2#-deoxycytidine (Sigma, Bornem, Belgium) or with the vehicle alone (phosphate buffered saline). On the last day, 2 mM sodium butyrate (NaB, Sigma) was added in some settings. For the nonsense-mediated decay (NMD) experiment, cells were treated with 100 lg/ml puromycin (Sigma) or with the vehicle alone (DMEM) for 15 h.
mRNA Expression Profiling by Real-Time Quantitative PCR Total RNA was isolated from cells using the RNeasy Mini Plus Kit (Qiagen, Westburg, Leusden, The Netherlands). For experiments on EVI5 and the total amount of NBPF, cDNA synthesis was performed using the iScript cDNA synthesis kit (Bio-Rad, Nazareth, Belgium). We determined the relative expression levels by an optimized two-step SYBR Green reverse transcription (RT)-PCR assay using the most stable housekeeping genes in neuroblastoma cell lines (Vandesompele et al. 2002) and the delta-Ct method for quantification. Fast SYBR Green Master Mix (Applied Biosystems) was used according to the manufacturer#s instructions, and reactions were run on a LightCycler 480 (Roche). NBPF transcripts were quantified as described (Vandepoele et al. 2008) . For the EVI5 NBPF transcript, we used primers 5#-TAATGTTTACGGCGAAGTCTAC-3# and 5#-TCTGACTGACTGTATGCGATAC-3#; for the EVI5 ALT transcript, we used primers 5#-ACAAAA-TGACTGCTGCCTTTAG-3# and 5#-TCTGACTGACTG-TATGCGATAC-3#. The total amount of EVI5 transcripts (EVI5 TOT ) was determined using primers with sequences obtained from Primer Bank (ID 19923325a2) (Wang and Seed 2003) . Primer sequences for procaspase-8 were obtained from RTPrimerDB (ID 86) (Pattyn et al. 2006) .
Bioinformatics
Analysis of the human genome sequences was done using BLAT at the UCSC Genome Browser (March 2006 Release). The NCBI Trace Archives were used to isolate primate sequences orthologous to the human EVI5 NBPF and NBPF1 promoter sequences. Sequences were aligned with ClustalX, and phylogenetic analysis was done with MEGA4 (Tamura et al. 2007 ). The Minimum Evolution method was used to build the phylogenetic tree. Similar results were obtained with the options ''Pairwise Deletion'' and ''Complete Deletion'' in the analysis of gaps.
The difference in the divergence between the Microcebus EVI5 NBPF sequence and the human EVI5 NBPF and NBPF1 sequences was tested using Tajima's Molecular Clock test as implemented in MEGA4. To detect positive evolution, we randomly selected 500-bp fragments on the short arm of chromosome 1 (supplementary table S1, Supplementary Material online). These fragments were located in intergenic regions and do not contain any repetitive elements as identified with the Repeatmasker track in the UCSC Genome Browser. Distances were calculated with MEGA4 using the Maximum Composite Likelihood method and statistical analysis was done with a one-sample t-test.
Results
The NBPF1 Promoter Was Most Likely Derived from the EVI5 Gene Before the Expansion of the NBPF Family
The NBPF gene family consists of genes that have recently been duplicated, and so they have a very high degree of sequence identity, both in coding and noncoding sequences (Vandepoele et al. 2005) . Analysis of the NBPF1 cDNA sequences available in GenBank showed a variety of transcription initiation sites spread over a genomic region of ;150 nt. We used the start position of the longest sequence (GenBank Acc No DA320506) as the þ1 site (see below). In this region, the FirstEF finder algorithm (Davuluri et al. 2001 ) predicts two overlapping promoters with a combined length of 1,055 bp. These sequences overlap the first NBPF1 exon and a CpG island of 998 nt (20.6% CpG). We used this 1,055-bp region to scan the human genome reference sequence (Build 36) and obtained nine hits (supplementary table S2, Supplementary Material online), all localized on chromosome 1. Most of the hits lie upstream of sequences that we previously annotated as functional NBPF genes (Vandepoele et al. 2005) . The NBPF proteins are composed of repetitive domains, which have previously been described as NBPF (Vandepoele et al. 2005) or DUF1220 repeats (Popesco et al. 2006) . One copy of this domain is also found in phosphodiesterase 4D interacting protein (PDE4DIP) and its paralogs, hinting at a common ancestral origin for these two gene families. We did not observe any similarity between the regulatory regions of these two gene families. Interestingly, we identified a region with significant homology to the 1,055-bp query sequence near a non-NBPF gene, EVI5. This gene is located on chromosome 1p22 and encodes a protein involved in vesicular trafficking (Westlake et al. 2007 ) and cell cycle control (Eldridge et al. 2006) . It was first identified by the breakpoint cloning of a constitutional translocation in a neuroblastoma patient (Roberts et al. 1998) .
The human EVI5 gene is transcribed as two isoforms differing in their transcriptional start sites and in their first exons ( fig. 1 ). For isoform 1 (henceforth referred to as EVI5 ALT ; RefSeq sequence NM_005665.4), the first exon spans nucleotides 93,030,489-93,030,549 on the reverse strand of chromosome 1 ( fig. 1 ). For isoform 2 (henceforth referred to as EVI5 NBPF as its promoter shows homology to the NBPF1 promoter), the location of the transcriptional start site varies within a region of 90 nt, and the first exon of the longest sequence is located from position 93,022,981 to 93,023,251 on the reverse strand of chromosome 1 ( fig. 1 ). As the first exon of EVI5 ALT is predicted to contain a start codon, alternative promoter usage will result in proteins with different aminoterminal domains. The first exon of isoform EVI5 NBPF does not contain a start codon, so probably an ATG located in the second exon is used as translation start of this isoform. As a result, isoform EVI5 ALT is 44 amino acid residues longer than isoform EVI5 NBPF . Although the first ATG of the EVI5 ALT isoform has a better Kozak sequence than the ATG in the second exon, it is also possible that the latter ATG is used for translation of both isoforms as no reports have been published on the exact translational start site of EVI5.
We determined the size of the region of homology between the NBPF genes and human EVI5 by isolating a fragment of 100 kb centered on the human EVI5 NBPF promoter. The NBPF genes do not have orthologs in the mouse genome (Vandepoele et al. 2005 ), but there is an ortholog for EVI5 in the mouse genome, so we also isolated a 100-kb sequence centered on the mouse EVI5 NBPF promoter. After masking the repeats, the sequences were aligned with the Vista Genome Browser (Frazer et al. This alignment showed that the region of homology is not limited to the core promoter but extends to a region of approximately 10 kb (for EVI5). In this region, there are different blocks of homology between the NBPF genes and EVI5, with NBPF1 showing the greatest similarity to EVI5. The gaps in the sequence similarity are caused mainly by the insertion of Alu repeats in the EVI5 locus. As shown in figure 1, the region of homology does not contain the EVI5 ALT promoter, which controls the expression of the EVI5 ALT isoform. Remarkably, the conservation between human and mouse EVI5 is less than between human EVI5 and human NBPF1 and corresponds almost exclusively to the two predicted promoters controlling the expression of the different EVI5 isoforms.
The NBPF1 Promoter Had Been Copied from EVI5 Before the Split between New World and Old World Monkeys and Suggests Positive Selection
We observed extensive sequence homology in the promoter region of the different NBPF paralogs, which means that the promoter recruitment occurred before the expansion of the human NBPF gene family. To determine when this event occurred, we queried the primate sequences available in the NCBI Trace Archives with a fragment of 405 nt of the EVI5 NBPF promoter. This fragment was selected because it is sufficient for promoter activity in a luciferase reporter assay (see below). We used the sequences from mouse (Mus) and rat (Rno) as outgroup sequences to build a rooted tree ( fig. 2A and supplementary fig. S2 , Supplementary Material online). For the human, chimpanzee, and macaque sequences, we annotated the NBPF sequences as NBPF1 on the basis of their syntenic chromosomal localization. For the other species, we selected the sequences that showed the highest homology to the human NBPF1 promoter.
The sequences we obtained for prosimians (Otolemur garnetti [Oga] and Microcebus murinus [Mic] ) are clustered in a branch separate from the simian sequences, showing that the EVI5 NBPF promoter had not been duplicated yet into the NBPF genes when these species emerged, even though we could identify NBPF orthologs in their genomes (data not shown). For the simians, we can clearly identify two branches, one containing the EVI5 NBPF sequences and another containing the NBPF1 sequences. Almost all simian species analyzed here contain sequences both in the EVI5 NBPF branch and in the NBPF branch, from which we can conclude that promoter duplication occurred after the split between prosimians and simians (80-85 million years ago, Ma), but before the divergence of the Old World and New World monkeys (40 Ma). Interestingly, for EVI5 NBPF , the tree is congruent with the accepted phylogenetic relationships between primates, but for the NBPF1 sequences, the two Old World monkeys (Macaca mulatta [Mmu] and Papio hamadryas [Pha]) do not cluster together. The NBPF1 sequences from the New World monkeys (Saimiri boliviensis [Sbo] and Callithrix jacchus [Cja] ) are clustered apart from the other NBPF1 sequences, mainly due to multiple small deletions that occurred in their last common ancestor.
When starting from the last common ancestral sequence of the EVI5 NBPF /NBPF promoter (marked with LCA, last common ancestor, in fig. 2A ), the branch of the subtree containing the NBPF1 sequences is longer than the branch of the EVI5 NBPF subgroup. To test the statistical significance of this observation, we performed Tajima's relative rate test on the human NBPF1 and EVI5 NBPF sequences using the Microcebus EVI5 NBPF sequence as the outgroup sequence (supplementary table S3, Supplementary Material online). This test showed that the null hypothesis (equality of evolutionary rate in human NBPF1 and human EVI5 NBPF ) could be rejected (P 5 0.02951). Similar results were obtained in the comparisons of the NBFP1/ EVI5 NBPF sequences of the other primates (data not shown). The observed difference can be the result of two mechanisms. Either the NBPF1 sequence evolved neutrally while the EVI5 NBPF sequence was under strong, negative, purifying selection, or the NBPF1 sequence underwent positive selection after promoter duplication. To determine which mechanism led to the observed difference, we randomly isolated 13 intergenic regions of 500 bp (free of repetitive elements) from the short arm of chromosome 1, assuming that they had evolved under neutral selection. The distances of the 13 human fragments from the orthologous fragments in the Microcebus genome were calculated using the maximum likelihood method (supplementary table S1, Supplementary Material online). The difference between the human NBPF1 and Microcebus EVI5 NBPF sequence is significantly larger than the differences between the intergenic regions (P , 0.001), suggesting that positive selection   FIG. 2. -Phylogenetic analysis of the NBPF and EVI5NBPF core promoter sequences. (A) The evolutionary history of a fragment of ;400 bp encompassing the EVI5 NBPF or NBPF1 core promoter was inferred using the Minimum Evolution method as implemented in MEGA4. Rodent EVI5 NBPF sequences (rat and mouse) were used as outgroup sequences. EVI5 NBPF sequences in simians (great apes, Old World monkeys, and New World monkeys) are clustered apart from the NBPF sequences, showing that promoter duplication occurred after the split between simians and prosimians, but before the divergence between Old World and New World monkeys (40 Ma). When compared with the EVI5 NBPF sequences, the NBPF sequences show a larger evolutionary distance from the last common ancestral EVI5 NBPF sequence shared with the prosimians (LCA). Only bootstrap values higher than 70 are shown. Great apes (Hsa: Homo sapiens, Ptr: Pan troglodytes, Ggo: Gorilla gorilla, and Ppy: Pongo pygmaeus) are shown in bold; Old World monkeys (Pha: Papio hamadryas, Mmu: Macaca mulatta) are underlined; New World monkeys (Sbo: Saimiri boliviensis, Cja: Callithrix jacchus) are shown in italics; prosimians (Mic: Microcebus murinus, Oga: Otolemur garnetti) are shown bold and underlined; rodents (Mus: Mus musculus, Rno: Rattus norvegicus) are in normal font. #: LCA of the NBPF1 sequences; *: LCA of the EVI5 NBPF sequences. (B) Sequence alignment of the human EVI5 NBPF and NBPF1 À295/þ116 regions. Of the 92 observed differences, 36 (shown as asterisks) occurred in the NBPF sequences before expansion of the simian lineage, as the nucleotides observed in the human NBPF1 sequence were also observed in the NBPF1 sequences of the other simians. The sequences were analyzed by ConTra (Hooghe et al. 2008 ) and only transcription factor binding sites overlapping the putative positively selected sites are shown. played a role in the evolution of the NBPF1 promoter. If positive selection played a role in the evolution of the NBPF1 promoter in simians, the evolutionary rate after simian divergence should slow down to retain the newly acquired function via purifying selection. Starting from their last common ancestor (marked with LCA in fig. 2A ), the branch leading to the NBPF1 LCA (marked with # in fig. 2A ) is 2.16 times longer than the one leading to the EVI5 NBPF LCA (marked with * in fig. 2A ). To investigate the evolutionary rate after simian radiation, we determined the branch lengths leading from the last common ancestral NBPF1 sequence (#) to individual NBPF1 sequences and compared these with the branches leading from the last common ancestral EVI5 NBPF (*) to the EVI5 NBPF sequence of the same species. Although the NBPF1 branches are longer than those of the EVI5 NBPF sequence of the same species (supplementary table S4, Supplementary Material online), the ratio is limited to 1.26 in the human lineage, suggesting a decrease in the evolutionary rate of the NBPF1 sequence after simian radiation. Even smaller differences between NBPF1 and EVI5 NBPF evolutionary rates were observed when the option ''complete deletion of gaps'' was used in the calculations (supplementary table S4, Supplementary Material online).
To search for sites that might have been subjected to positive selection, we identified the differences between the human NBPF1 and EVI5 NBPF sequences. Of the 92 observed differences ( fig. 2B ), 36 occurred in the NBPF sequences before expansion of the simian lineage, as the nucleotides observed in the human NBPF1 sequence were also observed in the NBPF1 sequences of the other simians. In contrast, only 14 changes occurred in the EVI5 NBPF sequence of the last common ancestor of the simian species. The 11-nt insertion in the 3# region of the NBPF1 sequence is present only in the human and chimpanzee sequences. To analyze the functional implications of these changes, we scanned the NBPF1 sequence for regulatory motifs using the ConTra tool (Hooghe et al. 2008 ) with the highest stringency settings. This allowed the use of the TRANSFAC (Matys et al. 2003) and Jaspar matrices (Vlieghe et al. 2006) as well as the phyloFACTS elements (Xie et al. 2005) . In figure 2B , we show the localization of the elements overlapping with the potentially positively selected sites. This analysis yielded 14 different putative regulatory elements.
The Macaque Genome Harbors NBPF Sequences in Close Proximity to EVI5 So far, there are complete genome sequences for four primates: human, chimpanzee, orangutan, and macaque. When comparing the NBPF sequences of these genomes, we observed the absence of an NBPF3 ortholog at the syntenic locations in the orangutan and macaque genomes, though it is found in its expected position in the chimpanzee genome. The two genes flanking NBPF3 in the human and chimpanzee genomes, ECE1 (distal) and ALPL (proximal), are found at the syntenic locations in the orangutan and macaque genomes, but without an NBPF3 ortholog in between. However, in our previous analysis of the expansion of the NBPF genes during primate evolution (Vandepoele et al. 2005) , we identified the macaque ortholog for the human NBPF3 gene (GenBank Acc No AY894630). When we used this sequence for a BLAT search against the macaque genome, the hit with the highest score was mapped to chromosome 1 around 94.1 Mbp (v1.0 of the M. mulatta genome assembly). Interestingly, this region is only 2 Mbp distal to the macaque EVI5 gene. The proximity of the NBPF sequences to the EVI5 gene probably facilitated recruitment of the EVI5 NBPF promoter to the NBPF sequences. In the human, chimpanzee, and orangutan genomes, there are no NBPF sequences at this location.
The Putative Promoter Fragments Induce Transcription of a Reporter Gene in a Variety of Cell Lines
To investigate the capacity of the putative NBPF1 and EVI5 promoter sequences to promote transcription, we cloned homologous fragments of 1,055 nt (NBPF1) or 1,084 nt (EVI5 NBPF ) into a promoterless luciferase reporter plasmid (fragment A in fig. 3A ). The 1,055-nt fragment encompasses the putative promoter sequences predicted by FirstEF and contains the first noncoding exon of NBPF1. Expression analysis showed that both NBPF1 and EVI5 NBPF are expressed in 293T cells (see the next section), demonstrating that all necessary transcription factors are expressed in these cells. Upon transfection of the promoter fragments in 293T cells, we observed promoter activity above background for both constructs ( fig. 3B ). To narrow down the core promoters, we constructed several deletion constructs of the two A fragments (fragments B-J in fig. 3A ). After transfection in 293T cells, we obtained similar patterns for the NBPF1 and EVI5 NBPF fragments ( fig. 3B ), although the luciferase levels were reproducibly higher for the respective NBPF1 fragments. Constructs lacking the À295/þ116 region (fragments B-D) showed almost no activity, whereas the NBPF1 and EVI5 NBPF À 295/þ116 region by itself (fragment G) is sufficient to drive transcription. The À295/þ116 sequence was also used in the phylogenetic analysis described above and was found to have been positively selected in the NBPF lineage. Surprisingly, when we used the shorter sequence of À82/þ116 (fragment H), the activity decreased significantly for the EVI5 NBPF construct, whereas the NBPF1 fragment H showed an increase in the luciferase activity. For EVI5 NBPF , even shorter fragments (J 3À4 ; see supplementary fig. S3 , Supplementary Material online, for sequences of the shorter fragments) showed activity similar to that of the H fragment. For NBPF1, however, both the 5# region (fragment J 1À2 ) and the 3# region (fragment I) showed a significant decrease in luciferase activity when compared with the H fragment, demonstrating that maximum activity requires both regions.
As described above, total EVI5 expression (EVI5 TOT ) is controlled by two different promoters: one sequence is homologous to the NBPF1 promoter (EVI5 NBPF ), but the other one is not (EVI5 ALT ). To compare these two promoters, we cloned a 1,500-bp fragment of the alternative promoter (EVI5 ALT ) in front of a luciferase reporter gene. This fragment showed only minor promoter activity when transfected into 293T cells ( fig. 3B ), similar to a shorter fragment of 930 nt (data not shown).
NBPF and EVI5 Expression Is Similar in a Panel of Human Cell Lines
Both NBPF1 (Vandepoele et al. 2008 ) and EVI5 (Roberts et al. 1998 ) are disrupted by constitutional translocations in neuroblastoma patients, classifying them as potential tumor suppressor genes. In the luciferase assays, we observed similar promoter activities (fragments A-G) as well as quite divergent activity (fragment H) for the homologous NBPF1 and EVI5 NBPF gene fragments. To test the expression pattern of the endogenous transcripts, we performed real-time quantitative RT-PCR analysis of the expression levels of the NBPF gene family and EVI5 transcripts in 8 human cell lines (fig. 4 ). For EVI5, we used 3 different amplicons: 1 amplicon (EVI5 TOT ) is located in the 3# region of the transcript and is present in all EVI5 isoforms; the other 2 amplicons (EVI5 NBPF and EVI5 ALT ) correspond to the 2 isoforms controlled by the 2 EVI5 promoters. The expression pattern of the EVI5 TOT transcript ( fig. 4B ) is similar to the previously reported expression analysis of the NBPF genes ( fig. 4A) (Vandepoele et al. 2008) . Also the EVI5 NBPF isoform shows a similar expression profile as the NBPF transcripts ( fig. 4C ). Hence, in the human cell lines tested here, the total EVI5 TOT expression level is almost exclusively due to the EVI5 NBPF promoter, as we observed only very weak expression for the EVI5 ALT transcript (fig. 4D ). The strongest expression of EVI5 ALT FIG. 3.-Deletion constructs of the NBPF1 and EVI5NBPF promoter are active in 293T cells. (A) Different promoter fragments were cloned in front of a luciferase reporter gene. The diagram shows only the NBPF1 fragments, but for fragments A-H and J, we also cloned the homologous EVI5 NBPF fragments. The fragment of 1,055 bp contains the first, noncoding exon as present in the sequence DA320506. The differences between the four J fragments are shown in supplementary figure S3, Supplementary Material online. (B) Equimolar amounts of the promoter constructs were transfected in 293T cells and the luciferase activity was tested 48 h later. The activity of the empty vector was set to 1. The region present in construct G is sufficient to drive transcription for both EVI5 NBPF and NBPF1. For the smaller H fragment, we observed a striking difference between EVI5 NBPF and NBPF1. Overall, the activity of the EVI5 NBPF fragments was slightly lower than that of the corresponding NBPF1 fragments. The alternative promoter EVI5 ALT shows only limited transcriptional activation. Mean values and standard deviations for two independent experiments are shown.
was found in HeLa cells, but it was still weak. We also observed substantial expression of the EVI5 ALT transcript in two murine cell lines (NMe and NIH3T3; data not shown).
The NBPF1 and EVI5 Promoters Are Active in Cell Lines with or without 1p Deletion Our previous analysis showed decreased NBPF1 expression in neuroblastoma cell lines with loss of heterozygosity for NBPF1 (Vandepoele et al. 2008) . As only 15-20% of the genes located in the 1p36 region show a similar decreased expression (Janoueix- Lerosey et al. 2004 ), other mechanisms besides gene dosage effects probably play a role. To test the presence of the necessary trans-acting factors in neuroblastoma cell lines, we transfected these cell lines with some of the promoter fragments (A, D, G, and H) we had tested in 293T cells. The EVI5 NBPF and NBPF1 promoter A fragments were active in all cell lines tested, including the murine cell line NIH3T3 (fig. 5) ; but the alternative EVI5 ALT promoter fragment showed activity only in HeLa cells, in which the EVI5 ALT transcript also showed the highest endogenous expression pattern ( fig. 4D) . The global activity pattern resembles the pattern observed   FIG. 4. -Quantitative RT-PCR analysis of NBPF and EVI5. Eight human cell lines were assayed for the expression of the entire NBPF family (A), the total EVI5 TOT amount (B), and the different EVI5 isoforms: EVI5 NBPF (C) and EVI5 ALT (D). For each amplicon, the expression level in 293T cells was set to 1. The expression patterns of EVI5 TOT and EVI5 NBPF resemble the NBPF expression pattern. For EVI5 ALT , we detected only very weak expression in 293T and STA-NB-1.2, and slightly stronger expression in HeLa cells. This shows that in these cell lines, the EVI5 TOT transcript level is mainly due to the activity of the EVI5 NBPF promoter.
FIG. 5.-Transfection of promoter fragments in several cell lines. One murine fibroblast cell line (NIH3T3), 1 human cervical carcinoma cell line (HeLa), and 4 neuroblastoma cell lines with high (SH-SY-5Y) or low (GI-ME-N, STA-NB-1.2, CHP901) endogenous levels of NBPF and EVI5, were transfected with different promoter constructs for EVI5 and NBPF1. The EVI5 ALT promoter showed activity only in HeLa cells, in line with the endogenous expression pattern in human cell lines (fig. 4) . Mean values and standard deviations for 2 independent experiments are shown. n.d.: no data.
for the fragments in 293T cells, where the G fragment (À295/ þ116) was sufficient to drive the expression of the luciferase reporter gene. The difference between EVI5 NBPF fragment H and NBPF1 fragment H was also observed in these cell lines, as NBPF1-H always showed more activity than NBPF1-G. Strikingly, the cell line with the highest luciferase values was GI-M-EN, a cell line with very low endogenous levels of NBPF transcripts (Vandepoele et al. 2008 ) and low EVI5 expression, hinting at additional levels of regulation of NBPF and EVI5 in this cell line.
Different Transcriptional and Posttranscriptional Regulation of NBPF1 and EVI5 in Neuroblastoma Cell Lines
The promoter fragmenttransfection experiments showed that all trans-acting factors needed under these conditions are present in the neuroblastoma cells used, even in cells with low endogenous NBPF and EVI5 NBPF expression level. The NBPF1 and EVI5 NBPF promoters contain a CpG island, the methylation of which can result in transcriptional silencing. To test the involvement of epigenetic regulation in the downregulation of NBPF and EVI5 NBPF expression in particular cell lines, we treated five neuroblastoma cell lines for 5 days with the demethylating agent 5-aza-2#-deoxycytidine (5-aza), or for 1 day with the histone deacetylase inhibitor NaB, or with both substances. As a control for the treatment, we assayed the expression level of procaspase-8, which is frequently silenced by methylation in neuroblastoma (Teitz et al. 2000) . The analysis of procaspase-8 revealed strong upregulation of the transcript in most cell lines, albeit to different degrees (supplementary fig.S4 ,SupplementaryMaterial online),showingthat the treatments were effective.
We observed only small increases in the expression of the NBPF transcripts in the different experimental setups, suggesting that NBPF1 and its paralogs are not silenced by methylation in these cell lines. In contrast, EVI5 NBPF expression was upregulated in all cell lines by at least one of the treatment strategies ( fig. 6A) .
Thus, the low expression levels of NBPF in some neuroblastoma cell lines could not be attributed to the absence of trans-acting factors or to epigenetic regulation. If there was a mutation in the NBPF or EVI5 genes, nonsensemediated decay (NMD) would probably remove the faulty transcripts before a protein can be made. To determine whether NMD plays a role in the regulation of NBPF and EVI5 NBPF expression levels in neuroblastoma cell lines, we treated the cells with puromycin, an inhibitor of NMD FIG. 6 .-Expression analysis of neuroblastoma cell lines. (A) Epigenetic regulation of NBPF and EVI5 NBPF . Five different neuroblastoma cell lines were either untreated (control) or treated with 5-aza-2#deoxycytidine (5-aza), NaB, or with both substances. The levels of NBPF and EVI5 NBPF transcripts were set to 1 for LA-N-5 control. The treatments did not markedly affect the levels of NBPF transcripts. However, the combination of 5-aza and NaB, and sometimes one of the treatments by itself, resulted in increased levels of EVI5 NBPF in every cell line. (B) NMD regulates the expression of NBPF and EVI5 NBPF . The same 5 neuroblastoma cell lines were treated with 100 lg/ml puromycin for 16 h. For each amplicon, the expression level in control samples was set to 1. In LA-N-5, the levels of both NBPF and EVI5 NBPF transcripts increased when the cells were treated with puromycin, but in SMS-KAN and STA-NB-1.2, only the NBPF levels increased under these conditions. This could indicate that the NBPF or EVI5 NBPF transcripts are mutated in these cell lines.
NBPF Promoter Analysis 1329 (Andreutti-Zaugg et al. 1997) . This led to an increase in the expression level of NBPF in STA-NB-1.2 and SMS-KAN, and an increase in the expression of both NBPF and EVI5 NBPF in LA-N-5 ( fig. 6B ). These results suggest that the NBPF transcripts are mutated in some neuroblastoma cell lines. In conclusion, although the NBPF and EVI5 NBPF promoter sequences are very similar and the NBPF1 and EVI5 genes show similar expression profiles, they are regulated in different ways in a panel of neuroblastoma cell lines.
Discussion
Gene duplications are the most important means by which an organism acquires new genes (Ohno 1970) . The new gene also has to obtain regulatory sequences. In most cases, the regulatory region of the parental gene is copied too, and subfunctionalization can later result in the paralogs having different expression patterns (Carroll 2005) . Here, we show that the regulatory region of the newly arisen NBPF gene family was obtained from an unrelated gene, EVI5, by an unknown mechanism. This occurred most likely after the split between simians and prosimians, but before the split between Old World and New World monkeys. Interestingly, the macaque genome contains NBPF sequences at a location near the EVI5 gene and these potentially represent an intermediate in the recruitment of the EVI5 promoter by the NBPF genes. A more thorough investigation of the way this promoter was obtained will require full genome sequences of prosimians. Although the genomes of some nonsimian mammals (such as dog, cow, and horse) contain NBPF orthologs, their regulatory sequences are not similar to the EVI5 NBPF promoter. It had been suggested a long time ago that evolution in regulatory sequences is responsible for the evolution of anatomic structures (King and Wilson 1975) . The recruitment of the EVI5 NBPF promoter to the NBPF genes might indeed have resulted in crucial differences in the expression patterns of the NBPF genes between prosimians and simians, potentially contributing to the differences between these species.
The phylogenetic tree with the NBPF1 and EVI5 NBPF sequences ( fig. 2A ) reveals two peculiarities. In the NBPF1 subtree, branches leading to the two New World Monkeys C. jacchus (Cja) and S. boliviensis (Sbo) are very long, both before and after these species separated from each other. Our previous analysis of the NBPF genes in different primates (Vandepoele et al. 2005 ) included the analysis of coding sequences of another New World monkey (Owl monkey, Aotus trivirgatus). In that analysis, we observed nonsense mutations in most of the NBPF genes, indicating that these are pseudogenes. It is possible that in the branch leading to New World monkeys, the NBPF genes were inactivated by mutations in the coding sequence, which relieved selective pressure from the promoter and therefore resulted in the observed longer phylogenetic tree branches. More transcript and genomic sequences have to be analyzed to determine the coding potential of the NBPF genes in these New World monkeys. The second anomaly in the tree is the position of the baboon NBPF1 sequence (P. hamadryas, Pha). For the EVI5 NBPF sequences, the baboon sequence is clustered with its Old World monkey relative, the macaque (Macaca mulatta; Mmu). However, in the branch with the NBPF1 sequences, the baboon is grouped with the great apes (Homo sapiens (Hsa), Pan troglodytes (Ptr), Gorilla gorilla (Ggo), and Pongo pygmaeus (Ppy) but only with a low bootstrap value (58%). One of the possible reasons for this unexpected localization is that our Pha NBPF sequence may not be the true ortholog of human NBPF1. Although we used the baboon sequence with the highest homology to the human NBPF1 promoter, the Trace Archives are not exhaustive and might not contain the real baboon NBPF1 sequence yet. Alternatively, a deletion in the baboon genome may have removed the true NBPF1 ortholog from this species.
Our evolutionary analysis suggests that the NBPF promoter sequences were positively selected after their duplication from the EVI5 gene, and that this happened before the simian radiation. To unequivocally prove the presence of positive selection acting on the simian NBPF promoter, a new function for this promoter should be observed, which is then shared among the simian NBPF1 promoter sequences. Unfortunately, so far we have been unable to detect a difference in the response of the cloned NBPF1 and EVI5 NBPF promoter fragments when we treated transfected cells with various stimuli (data not shown). Nevertheless, in our functional assays of the promoter regions, we did observe a striking difference in the activity of the H fragments of EVI5 NBPF and NBPF1. It is unclear, however, whether the observed differences are due to positive selection. To investigate this further, the set of promoters should be expanded to include all the primate NBPF and EVI5 NBPF sequences. For instance, the NBPF1 sequence has an 11-nt insertion that is present only in the human and chimpanzee sequences. It is possible that the difference between the activity of the H fragments of EVI5 NBPF and NBPF1 is due to the recent insertion of this 11-nt sequence in the NBPF1 sequence.
The similarity between the promoter regions of the NBPF genes and EVI5 NBPF suggests a similar transcriptional regulation. Genes regulated by similar sets of cisand trans-acting regulators make up so-called gene batteries (Nelander et al. 2005) composed of functionally linked genes. Coimmunoprecipitation of the overexpressed proteins did not reveal an interaction between EVI5 and NBPF1 proteins (data not shown). Several functions have been described for EVI5, but the function of NBPF proteins is not known, making it difficult to identify a functional link between these two proteins. The EVI5 protein participates in regulating the cell cycle by stabilizing the anaphasepromoting complex inhibitor Emi1 (Eldridge et al. 2006) . Interestingly, the EVI5 protein level is regulated during the cell cycle, reaching a maximum in G1 and S/ G2 phases. However, northern blot analysis showed that the level of EVI5 mRNA remained unchanged (Eldridge et al. 2006) , suggesting that transcriptional regulation is not the cause of the observed accumulation of the protein in the G1 phase.
Both NBPF1 (Vandepoele et al. 2008 ) and EVI5 (Roberts et al. 1998) were discovered by the breakpoint cloning of constitutional translocations in two neuroblastoma patients. These tumors are derived from neural crest cells and show extensive clinical and biological heterogeneity (Brodeur 2003) . We previously showed that expression of NBPF transcripts is diminished in cell lines with loss of heterozygosity of the 1p chromosome (Vandepoele et al. 2008) . Here, we show in a smaller set of cell lines that the EVI5 NBPF transcripts mimic this expression pattern, with low EVI5 NBPF expression in cell lines having low NBPF levels, and vice versa. Apart from its disruption in a constitutional translocation, no correlation has been made between EVI5 and neuroblastoma. Although the promoter sequences of NBPF1 and EVI5 NBPF are almost identical, and the resulting expression levels show a similar trend, we have shown in a panel of neuroblastoma cells that these two genes are regulated differently. We could not observe any epigenetic regulation of the NBPF genes, neither by methylation nor by histone deacetylation. For the EVI5 NBPF transcript, we observed a significant influence by epigenetic regulation in every cell line analyzed. On the other hand, we observed upregulation of NBPF transcripts when we treated cells with puromycin, an inhibitor of NMD, in 3 of 5 cell lines tested, whereas for EVI5 NBPF , this was the case in 1 cell line only. This shows that even though the promoter sequences and the expression profiles of NBPF and EVI5 NBPF are similar, the genes are regulated in different ways. The upregulation of the NBPF transcripts by puromycin suggests that these transcripts are mutated in these cell lines. Unfortunately, mutational analysis of the NBPF genes is hardly feasible because every cell contains transcripts of numerous NBPF paralogs with remarkably high sequence identity.
A few examples of promoter duplication are known in invertebrates (Nurminsky et al. 1998; Betran and Long 2003; Usakin et al. 2005) . Here, we describe the duplication of a primate promoter and its recruitment to an unrelated gene. Although the NBPF and EVI5 NBPF expression levels are similar, we observed striking differences in the regulatory sequences controlling this expression and in the transcriptional and posttranscriptional regulation of the endogenous genes. Mounting indirect evidence suggests that the NBPF genes play a role in the development of the brain (Popesco et al. 2006; Dumas et al. 2007 ) and that the genomic loci comprising the NBPF genes show copy number variations in patients with mental retardation (Mefford et al. 2008) , autism (Sharp et al. 2006) , and schizophrenia (Stefansson et al. 2008) . Further research into the functions of the NBPF proteins and the transcriptional elements controlling their expression is needed to determine their precise roles in neural development and pathologies.
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